Skip to main content

New treatment for diabetics undergoes trial

A treatment that could mean the end of daily insulin injections for diabetics is about to undergo trials in the UK.

Brought to you bySPIS MedWire
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

A treatment that could mean the end of daily insulin injections for diabetics is about to undergo trials in the UK.

The treatment was developed in Canada by British-born surgeon James Shapiro and involves the transplantation of insulin-producing cell clusters into the livers of diabetics, so that they can create insulin themselves (N Engl J Med 2000, 343:230-238). The treatment has already be used on 15 Canadian patients, 13 of whom have been effectively 'cured' and have not needed to inject insulin for two years.

The charity Diabetes UK is funding seven centres at British hospitals to test the technique, at a cost of £300,000. Ten patients will receive the cell transplants and, if successful, the project will be expanded to treat up to 400 diabetics a year.

To prevent the cell transplant from being rejected these patients will be treated with a cocktail of drugs and, as the potential ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo